How many insider trades does FilingIQ track for GOVX?

FilingIQ tracks 70 Form 4 insider transactions for GOVX (GeoVax Labs, Inc.), covering filings from Mar 19, 2015 onwards. 11 of those were filed in the last 90 days.

Are GOVX insiders net buyers or net sellers?

Across the full Form 4 history for GOVX, 33 transactions (47%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does GOVX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is GOVX in?

GeoVax Labs, Inc. (GOVX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.16M.

GOVX insider trading

NasdaqCM Healthcare

GeoVax Labs, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

47% / 0%

Market cap

$4.16M

About GeoVax Labs, Inc.

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. It also developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.

Company website: www.geovax.com

GOVX insider activity at a glance

FilingIQ has scored 70 insider transactions for GOVX since Mar 19, 2015. The most recent filing in our index is dated Jun 17, 2026.

Across the full history, 33 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on GOVX insider trades is 60.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live GOVX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,196

UNITED THERAPEUTICS Corp

APLS 275

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

GH 191

Guardant Health, Inc.

First Tracks Biotherapeutics, Inc.

NTRA 133

Natera, Inc.

Frequently asked

How many insider trades does FilingIQ track for GOVX?: FilingIQ tracks 70 Form 4 insider transactions for GOVX (GeoVax Labs, Inc.), covering filings from Mar 19, 2015 onwards. 11 of those were filed in the last 90 days.
Are GOVX insiders net buyers or net sellers?: Across the full Form 4 history for GOVX, 33 transactions (47%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does GOVX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is GOVX in?: GeoVax Labs, Inc. (GOVX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $4.16M.

Methodology & sources

Every GOVX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.